Dapagliflozin 10mg Tab trials for Chronic kidney disease

All Dapagliflozin 10mg Tab trials · All Chronic kidney disease trials

Phase breakdown

Recruiting trials studying Dapagliflozin 10mg Tab for Chronic kidney disease

• Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
  NCT06560801 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease
  NCT07405216 · Phase: Phase 4 · Ages: 14 Years to 18 Years · Sex: All (male and female) · 1 location
• SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
  NCT05852704 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
  NCT06155604 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Dapagliflozin 10mg Tab for Chronic kidney disease?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.